Aqr Capital Management LLC Arbutus Biopharma Corp Transaction History

Aqr Capital Management LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$1.9 - $2.27 $49,542 - $59,190	26,075 Added 179.54%	40,598 $82,000
Q2 2023 Aug 14, 2023	SELL	$2.24 - $3.06 $14,362 - $19,620	-6,412 Reduced 30.63%	14,523 $33,000
Q1 2023 May 15, 2023	SELL	$2.23 - $3.1 $4,054 - $5,635	-1,818 Reduced 7.99%	20,935 $63,000
Q4 2022 Feb 14, 2023	SELL	$1.91 - $2.85 $131 - $196	-69 Reduced 0.3%	22,753 $53,000
Q3 2022 Nov 14, 2022	BUY	$1.88 - $2.88 $6,376 - $9,768	3,392 Added 17.46%	22,822 $44,000

Q2 2022 Aug 15, 2022	BUY	$1.98 - $3.17 $38,471 - $61,593	19,430 New	19,430 $53,000
Q3 2021 Nov 15, 2021	SELL	$2.65 - $4.62 $50,445 - $87,946	-19,036 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$2.5 - $3.51 $47,590 - $66,816	19,036 New	19,036 $58,000
Q2 2019 Aug 14, 2019	SELL	$1.46 - $4.44 $41,066 - $124,888	-28,128 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$3.41 - $4.57 $318,882 - $427,358	-93,514 Reduced 76.88%	28,128 $101,000
Q4 2018 Feb 14, 2019	BUY	$3.5 - $9.66 $262,731 - $725,137	75,066 Added 161.17%	121,642 $466,000
Q3 2018 Nov 15, 2018	BUY	$7.85 - $12.35 $214,728 - $337,821	27,354 Added 142.31%	46,576 $440,000
Q2 2018 Aug 14, 2018	BUY	$5.0 - $7.35 $96,110 - $141,281	19,222 New	19,222 $140,000

130

82.2M

4.82M

546K

Ticker ABUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,951,008
Market Cap $489M
Description
Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aqr Capital Management LLC with notifications on news.